Kylie McLaughlin

Kylie McLaughlin is an Associate Principal Scientist at CV6 Therapeutics, (NI) Ltd., with a background in research, teaching, and visiting scholar roles at Queen's University Belfast and Karolinska Institutet. Kylie completed their Doctor of Philosophy in Medicine (Oncology) and has experience in molecular biology techniques, laboratory demonstration, and teaching assistance in medical programs. Kylie has also researched drug resistance and chemotherapy combination treatments in colorectal cancer models.